Tashkent, Uzbekistan (UzDaily.com) —  Sechenov University of the Ministry of Health of Russia has signed an agreement with the Republican Specialized Scientific and Practical Center of Cardiology of the Ministry of Health of the Republic of Uzbekistan to conduct a trial of the "Virtual FFR" system. This system is designed for non-invasive assessment of coronary blood flow and planning surgeries for the treatment of vessel stenosis.

The aim of this project is to improve the system’s database, which will enhance its diagnostic accuracy and demonstrate its clinical and economic effectiveness, safety, and convenience compared to traditional invasive methods. The research is part of the National Center for Medical University’s (NCMU) "Digital BioDesign and Personalized Healthcare" program.

The "Virtual FFR" system allows for non-invasive assessment of stenosis severity in coronary arteries. All that is required to run the program is internet access and a web browser.

The results of the studies will enable doctors to accurately evaluate the functional parameters of coronary blood flow and determine the significance of stenosis, taking into account collateral circulation.

The testing of the system will take place at the Republican Specialized Scientific and Practical Center of Cardiology over a period of two months, during which data from 30 patients will be analyzed. The results will be compared with diagnostic coronary angiography, which uses a special pressure sensor in the coronary artery and is considered the "gold standard" for assessing the functional severity of stenosis. In the future, the system may be implemented at the regional branches of the center, noted the director of the center, Khurshid Fozilov.

"This program allows for early assessment to determine whether the patient needs surgery and what the potential outcome will be," explained Philip Kopylov, Director of the Institute of Personalized Cardiology at Sechenov University. "In addition to coronary blood flow, the system takes into account parameters such as the elasticity of coronary vessels, making the prognosis even more accurate."

The "Virtual FFR" trials are also being conducted at Sechenov University’s Clinical Center. Upon successful completion of the trials, scientists will be able to obtain a registration certificate for the technology, enabling its broader clinical use.